Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors

Core Insights - Personalis, Inc. has published a new study in Clinical Cancer Research, highlighting advancements in genomics for precision oncology [1] Company Summary - The study titled "Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy" was conducted by Dr. Rodrigo Toledo and a leading team at the Vall d'Hebron Institute of Oncology (VHIO) [1]